These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15157259)

  • 1. Patient care during infusion of hematopoietic progenitor cells.
    Sauer-Heilborn A; Kadidlo D; McCullough J
    Transfusion; 2004 Jun; 44(6):907-16. PubMed ID: 15157259
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion.
    Júnior AM; Arrais CA; Saboya R; Velasques RD; Junqueira PL; Dulley FL
    Bone Marrow Transplant; 2008 Jan; 41(1):95-6. PubMed ID: 17934528
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute haemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation.
    Burger J; Gilmore MJ; Jackson B; Prentice HG
    Bone Marrow Transplant; 1991 Apr; 7(4):322-4. PubMed ID: 2070140
    [No Abstract]   [Full Text] [Related]  

  • 4. Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
    González-López TJ; Sánchez-Guijo FM; Ortín A; Crusoe E; Cordoba I; Corral M; Vazquez L; Caballero MD
    Bone Marrow Transplant; 2011 Jul; 46(7):1035-6. PubMed ID: 20956954
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
    Hoyt R; Szer J; Grigg A
    Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide.
    Cox MA; Kastrup J; Hrubiško M
    Cell Tissue Bank; 2012 Jun; 13(2):203-15. PubMed ID: 21394484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
    Lakota J; Fuchsberger P
    Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
    Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
    Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT.
    Abdelkefi A; Lakhal A; Moojat N; Hamed LB; Fekih J; Ladeb S; Torjman L; Othman TB
    Bone Marrow Transplant; 2009 Sep; 44(5):323-4. PubMed ID: 19234515
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation.
    Nishihara G; Sakemi T; Ikeda Y; Baba N; Shimamoto Y
    Nephron; 1996; 72(2):356-7. PubMed ID: 8684570
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
    Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
    Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe respiratory depression after autologous bone marrow infusion.
    Miniero R; Vai S; Giacchino M; Giubellino C; Madon E
    Haematologica; 1992; 77(1):98-9. PubMed ID: 1383102
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood.
    Rodrigues JP; Paraguassú-Braga FH; Carvalho L; Abdelhay E; Bouzas LF; Porto LC
    Cryobiology; 2008 Apr; 56(2):144-51. PubMed ID: 18313656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMSO induced myocardial infarction during allogeneic cryopreserved bone marrow transplant.
    Khawandanah M; Hopps S; Nabeel S; Ahmad B; Weiss S; Holter Charkrabarty J; Yuen C; Selby G
    Ann Hematol; 2015 Mar; 94(3):511-3. PubMed ID: 25135449
    [No Abstract]   [Full Text] [Related]  

  • 18. Conditions for cryopreservation of human bone marrow for use in autologous transplantation.
    Harada M; Ishino C; Odaka K; Matsue K; Shiobara S; Kodo H; Mori T; Hattori K
    Nihon Ketsueki Gakkai Zasshi; 1982 Jul; 45(4):754-62. PubMed ID: 6753439
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
    Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
    Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5% Me2SO is sufficient to preserve stem cells derived from cord blood.
    Richter E; Eichler H; Raske D; Leveringhaus A; Zieger W; Kerowgan M; Goldmann SF
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S16. PubMed ID: 9715875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.